Vulvar lichen sclerosus - Effect of long-term topical application of a potent steroid on the course of the disease

被引:129
作者
Renaud-Vilmer, C
Cavelier-Balloy, B
Porcher, R
Dubertret, L
机构
[1] Ctr Anticanc Rene Huguenin, Dept Dermatol, St Cloud, France
[2] Hop St Louis, Assiscance Publ Hop Paris, Dept Dermatol, F-75475 Paris, France
[3] Hop St Louis, Assiscance Publ Hop Paris, Dept Pathol, F-75475 Paris, France
[4] Hop St Louis, Assiscance Publ Hop Paris, Dept Biostat & Med Informat, F-75475 Paris, France
关键词
D O I
10.1001/archderm.140.6.709
中图分类号
R75 [皮肤病学与性病学];
学科分类号
100206 ;
摘要
Background: Lichen sclerosus is an inflammatory disease of unknown etiology affecting the anogenital skin and associated with the development of squamous cell carcinoma. It is not known whether long-term topical treatment with a potent steroid can cure this disease and thus prevent malignant evolution. Objectives: To analyze the rates of remission, recurrence, and chronic evolution of vulvar lichen sclerosus (VLS) treated with 0.05% clobetasol propionate ointment and determine whether this treatment can decrease the risk of malignant evolution. Design: Prospective study, conducted between 1981 and 2001, of 83 women with VLS who were treated until complete clinical and histologic remission and followed up for evidence of clinical and histologic recurrence (median follow-up, 4.7 years). Setting: Dermatology department, of a large urban teaching hospital. Results: Complete remission was obtained in 45 patients (54%). The probability of remission was significantly associated with age (P<.001). The estimated incidence of remission at 3 years was 72% in women younger than 50 years, 23% in women aged between 50 and 70 years, and 0% in women older than 70 years. The incidence of relapse was estimated to be 50% at 16 months (95% confidence interval, 30%-64%) and 84% at 4 years (95% confidence interval, 57%-94%). Age had no effect on relapse prevalence. The 8 observed vulvar squamous cell carcinomas (9.6%) occurred in previously untreated or irregularly treated VLS lesions. Conclusions: Treatment with a potent steroid cream can improve but does not cure VLS in women older than 70 years, probably because of along disease evolution. In younger patients who achieve complete remission, it seems to have only a temporary effect. Although a protective effect from malignant evolution is suggested (carcinoma developed only in nontreated or irregularly treated VLS lesions), the number of seemingly protected patients was too small to be statistically significant.
引用
收藏
页码:709 / 712
页数:4
相关论文
共 20 条
[1]   Successful treatment of anogenital lichen sclerosus with topical tacrolimus [J].
Böhm, M ;
Frieling, U ;
Luger, TA ;
Bonsmann, G .
ARCHIVES OF DERMATOLOGY, 2003, 139 (07) :922-924
[2]   Clobetasol dipropionate 0.05% versus testosterone propionate 2% topical application for severe vulvar lichen sclerosus [J].
Bornstein, J ;
Heifetz, S ;
Kellner, Y ;
Stolar, Z ;
Abramovici, H .
AMERICAN JOURNAL OF OBSTETRICS AND GYNECOLOGY, 1998, 178 (01) :80-84
[3]  
BRACCO GL, 1993, J REPROD MED, V38, P37
[4]   SQUAMOUS-CELL CARCINOMA ARISING IN VULVAR LICHEN-SCLEROSUS - A LONGITUDINAL COHORT STUDY [J].
CARLI, P ;
CATTANEO, A ;
DEMAGNIS, A ;
BIGGERI, A ;
TADDEI, G ;
GIANNOTTI, B .
EUROPEAN JOURNAL OF CANCER PREVENTION, 1995, 4 (06) :491-495
[5]   Penile lichen sclerosus et atrophicus treated with clobetasol dipropionate 0.05% cream: A retrospective clinical and histopathologic study [J].
Dahlman-Ghozlan, K ;
Hedblad, MA ;
von Krogh, G .
JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY, 1999, 40 (03) :451-457
[6]  
DALZIEL KL, 1993, J REPROD MED, V38, P25
[7]  
DAZIEL KL, 1991, BRIT J DERMATOL, V124, P461
[8]   A proportional hazards model for the subdistribution of a competing risk [J].
Fine, JP ;
Gray, RJ .
JOURNAL OF THE AMERICAN STATISTICAL ASSOCIATION, 1999, 94 (446) :496-509
[9]   Ultrapotent topical corticosteroid treatment of childhood genital lichen sclerosus [J].
Garzon, MC ;
Paller, AS .
ARCHIVES OF DERMATOLOGY, 1999, 135 (05) :525-528
[10]   A CLASS OF K-SAMPLE TESTS FOR COMPARING THE CUMULATIVE INCIDENCE OF A COMPETING RISK [J].
GRAY, RJ .
ANNALS OF STATISTICS, 1988, 16 (03) :1141-1154